In patients with squamous cervical cancer, APOA1 overexpression can reduce the sensitivity of cervical squamous cells to carboplatin by regulating the expression of STAT1, CD81, C3, and TOP2A [19]. The gene discussed is TOP2A; the disease is cervical squamous cell carcinoma.